Literature DB >> 25734952

The utility of rodent models of autism spectrum disorders.

Maria T Lázaro1, Peyman Golshani.   

Abstract

PURPOSE OF REVIEW: This review discusses the ways that rodent models of autism spectrum disorders (ASDs) have been used to gain critical information about convergent molecular pathways, the mechanisms underlying altered microcircuit structure and function, and as a screen for potential cutting edge-treatments for ASDs. RECENT
FINDINGS: There is convergent evidence that impaired developmental pruning of connections may be a common finding among several mouse models of ASDs. Recent studies have uncovered impaired autophagy by pathological mTOR activation as a potential contributor to microcircuit dysfunction and behavior. ASD-related disinhibition and exaggerated synaptic plasticity in multiple distinct circuits in cortex and reward circuits in striatum also contribute to social dysfunction and repetitive behaviors. New exciting molecular therapeutic techniques have reversed cognitive deficits in models of ASD, indicating that mouse models could be used for preclinical translational studies of new treatments.
SUMMARY: Rodent models of ASDs coupled to new emerging technologies for genome editing, cell-specific functional and structural imaging, and neuronal activity manipulation will yield critical insights into ASD pathogenesis and fuel the emergence of new treatments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25734952      PMCID: PMC4476903          DOI: 10.1097/WCO.0000000000000183

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  60 in total

1.  Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Authors:  Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

2.  Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring.

Authors:  Roman Tyzio; Romain Nardou; Diana C Ferrari; Timur Tsintsadze; Amene Shahrokhi; Sanaz Eftekhari; Ilgam Khalilov; Vera Tsintsadze; Corinne Brouchoud; Genevieve Chazal; Eric Lemonnier; Natalia Lozovaya; Nail Burnashev; Yehezkel Ben-Ari
Journal:  Science       Date:  2014-02-07       Impact factor: 47.728

3.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

Review 4.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

5.  Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors.

Authors:  Patrick E Rothwell; Marc V Fuccillo; Stephan Maxeiner; Scott J Hayton; Ozgun Gokce; Byung Kook Lim; Stephen C Fowler; Robert C Malenka; Thomas C Südhof
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

6.  Neurexin dysfunction in adult neurons results in autistic-like behavior in mice.

Authors:  Luis G Rabaneda; Estefanía Robles-Lanuza; José Luis Nieto-González; Francisco G Scholl
Journal:  Cell Rep       Date:  2014-07-10       Impact factor: 9.423

7.  Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.

Authors:  Aubin Michalon; Andreas Bruns; Céline Risterucci; Michael Honer; Theresa M Ballard; Laurence Ozmen; Georg Jaeschke; Joseph G Wettstein; Markus von Kienlin; Basil Künnecke; Lothar Lindemann
Journal:  Biol Psychiatry       Date:  2013-07-30       Impact factor: 13.382

8.  Overexpression of calcium-activated potassium channels underlies cortical dysfunction in a model of PTEN-associated autism.

Authors:  Pablo Garcia-Junco-Clemente; David K Chow; Elaine Tring; Maria T Lazaro; Joshua T Trachtenberg; Peyman Golshani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

9.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

10.  Long-term dynamics of CA1 hippocampal place codes.

Authors:  Yaniv Ziv; Laurie D Burns; Eric D Cocker; Elizabeth O Hamel; Kunal K Ghosh; Lacey J Kitch; Abbas El Gamal; Mark J Schnitzer
Journal:  Nat Neurosci       Date:  2013-02-10       Impact factor: 24.884

View more
  12 in total

Review 1.  Emerging connections between cerebellar development, behaviour and complex brain disorders.

Authors:  Aaron Sathyanesan; Joy Zhou; Joseph Scafidi; Detlef H Heck; Roy V Sillitoe; Vittorio Gallo
Journal:  Nat Rev Neurosci       Date:  2019-05       Impact factor: 34.870

Review 2.  Sex Differences in Autism Spectrum Disorder: Diagnostic, Neurobiological, and Behavioral Features.

Authors:  Antonio Napolitano; Sara Schiavi; Piergiorgio La Rosa; Maria Camilla Rossi-Espagnet; Sara Petrillo; Francesca Bottino; Emanuela Tagliente; Daniela Longo; Elisabetta Lupi; Laura Casula; Giovanni Valeri; Fiorella Piemonte; Viviana Trezza; Stefano Vicari
Journal:  Front Psychiatry       Date:  2022-05-13       Impact factor: 5.435

3.  Modulation of sphingosine 1-phosphate (S1P) attenuates spatial learning and memory impairments in the valproic acid rat model of autism.

Authors:  Hongmei Wu; Quanzhi Zhang; Jingquan Gao; Caihong Sun; Jia Wang; Wei Xia; Yonggang Cao; Yanqiu Hao; Lijie Wu
Journal:  Psychopharmacology (Berl)       Date:  2017-12-07       Impact factor: 4.530

4.  Exploiting aberrant mRNA expression in autism for gene discovery and diagnosis.

Authors:  Jinting Guan; Ence Yang; Jizhou Yang; Yong Zeng; Guoli Ji; James J Cai
Journal:  Hum Genet       Date:  2016-04-30       Impact factor: 4.132

5.  Astrocytes restore connectivity and synchronization in dysfunctional cerebellar networks.

Authors:  Sivan Kanner; Miri Goldin; Ronit Galron; Eshel Ben Jacob; Paolo Bonifazi; Ari Barzilai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

6.  Abnormal behaviours relevant to neurodevelopmental disorders in Kirrel3-knockout mice.

Authors:  Tomoko Hisaoka; Tadasuke Komori; Toshio Kitamura; Yoshihiro Morikawa
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

7.  Immature Neurons and Radial Glia, But Not Astrocytes or Microglia, Are Altered in Adult Cntnap2 and Shank3 Mice, Models of Autism.

Authors:  Elise C Cope; Brandy A Briones; Adam T Brockett; Susana Martinez; Pierre-Antoine Vigneron; Maya Opendak; Samuel S-H Wang; Elizabeth Gould
Journal:  eNeuro       Date:  2016-10-17

Review 8.  Autophagy deficiency in neurodevelopmental disorders.

Authors:  Zhiqiang Deng; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Cell Biosci       Date:  2021-12-17       Impact factor: 7.133

Review 9.  Empathy Study in Rodent Model of Autism Spectrum Disorders.

Authors:  Tamanna Jahan Mony; Minha Hong; Hee Jae Lee
Journal:  Psychiatry Investig       Date:  2017-12-14       Impact factor: 2.505

Review 10.  Relationship between Autism Spectrum Disorder and Pesticides: A Systematic Review of Human and Preclinical Models.

Authors:  Judit Biosca-Brull; Cristian Pérez-Fernández; Santiago Mora; Beatriz Carrillo; Helena Pinos; Nelida Maria Conejo; Paloma Collado; Jorge L Arias; Fernando Martín-Sánchez; Fernando Sánchez-Santed; Maria Teresa Colomina
Journal:  Int J Environ Res Public Health       Date:  2021-05-13       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.